Page last updated: 2024-08-17

cytidine triphosphate and Disease Models, Animal

cytidine triphosphate has been researched along with Disease Models, Animal in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barten-Van Rijbroek, AD; Kal, HB; Leen, R; Rodermond, HM; Van Bree, C; Van Kuilenburg, AB1
Arseniev, AS; Boychuk, YA; Grishin, EV; Korolkova, YV; Krishtal, OO; Kulyk, VB; Nadezhdin, KD; Pluzhnikov, KA; Savchenko, GA; Vassilevski, AA; Viatchenko-Karpinski, VY; Voitenko, NV1
Bapiro, TE; Cook, N; Frese, KK; Goldgraben, MA; Griffiths, JR; Jacobetz, MA; Jodrell, DI; Madhu, B; Olive, KP; Richards, FM; Smith, DM; Tuveson, DA1

Other Studies

3 other study(ies) available for cytidine triphosphate and Disease Models, Animal

ArticleYear
Cyclopentenyl cytosine has biological and anti-tumour activity, but does not enhance the efficacy of gemcitabine and radiation in two animal tumour models.
    International journal of oncology, 2009, Volume: 34, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Combined Modality Therapy; Cytidine; Cytidine Triphosphate; Deoxycytidine; Disease Models, Animal; Drug Synergism; Female; Gemcitabine; Humans; Lung Neoplasms; Mice; Mice, Nude; Middle Aged; Pancreatic Neoplasms; Rats; Rats, Inbred BN

2009
Novel peptide from spider venom inhibits P2X3 receptors and inflammatory pain.
    Annals of neurology, 2010, Volume: 67, Issue:5

    Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Cells, Cultured; Chondrus; Cytidine Triphosphate; Disease Models, Animal; Dose-Response Relationship, Drug; Ganglia, Spinal; Humans; Magnetic Resonance Spectroscopy; Membrane Potentials; Neurogenic Inflammation; Pain; Patch-Clamp Techniques; Peptides; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P2; Receptors, Purinergic P2X3; Sensory Receptor Cells; Spider Venoms; Transfection

2010
A novel method for quantification of gemcitabine and its metabolites 2',2'-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS/MS: comparison with (19)F NMR spectroscopy.
    Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:5

    Topics: Animals; Antineoplastic Agents; Calibration; Cytidine Triphosphate; Deoxycytidine; Disease Models, Animal; Floxuridine; Fluorine; Gemcitabine; Humans; Magnetic Resonance Spectroscopy; Mice; Reference Standards; Tandem Mass Spectrometry

2011